These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10704653)

  • 1. Stimulating effect of biologically modified low density lipoproteins on ADP-induced aggregation of washed platelets persists in absence of specific binding.
    Volf I; Roth A; Moeslinger T; Cooper J; Schmid W; Zehetgruber M; Koller E
    Thromb Res; 2000 Mar; 97(6):441-9. PubMed ID: 10704653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypochlorite modified LDL are a stronger agonist for platelets than copper oxidized LDL.
    Volf I; Roth A; Cooper J; Moeslinger T; Koller E
    FEBS Lett; 2000 Oct; 483(2-3):155-9. PubMed ID: 11042272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of oxidized low density lipoproteins on ADP-induced platelet aggregation in plasma].
    Vlasova II; Vakhrusheva TV; Azizova OA; Lopukhin IuM
    Vopr Med Khim; 1998; 44(1):43-54. PubMed ID: 9575612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of protein moiety of human low density lipoprotein by hypochlorite generates strong platelet agonist.
    Volf I; Bielek E; Moeslinger T; Koller F; Koller E
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2011-8. PubMed ID: 10938025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LDLs increase the exposure of fibrinogen binding sites on platelets and secretion of dense granules.
    van Willigen G; Gorter G; Akkerman JW
    Arterioscler Thromb; 1994 Jan; 14(1):41-6. PubMed ID: 8274476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LDL oxidized by hypochlorous acid causes irreversible platelet aggregation when combined with low levels of ADP, thrombin, epinephrine, or macrophage-derived chemokine (CCL22).
    Coleman LG; Polanowska-Grabowska RK; Marcinkiewicz M; Gear AR
    Blood; 2004 Jul; 104(2):380-9. PubMed ID: 15054038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclin.
    Hassall DG; Owen JS; Bruckdorfer KR
    Biochem J; 1983 Oct; 216(1):43-9. PubMed ID: 6360159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of low density lipoprotein from insulin-dependent diabetic patients on platelet functions.
    Rabini RA; Staffolani R; Martarelli D; Fumelli P; Ravaglia F; Dousset N; Curatola G; Mazzanti L
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3770-4. PubMed ID: 10523028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of (E)-4-hydroxy-2-nonenal in platelet activation by low density lipoprotein and iron.
    Selley ML; Bartlett MR; Czeti AL; Ardlie NG
    Atherosclerosis; 1998 Sep; 140(1):105-12. PubMed ID: 9733221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-density lipoproteins inhibit the Na+/H+ antiport in human platelets. A novel mechanism enhancing platelet activity in hypercholesterolemia.
    Nofer JR; Tepel M; Kehrel B; Wierwille S; Walter M; Seedorf U; Zidek W; Assmann G
    Circulation; 1997 Mar; 95(6):1370-7. PubMed ID: 9118502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Native and modified low-density-lipoprotein interaction with human platelets in normal and homozygous familial-hypercholesterolaemic subjects.
    Shmulewitz A; Brook JG; Aviram M
    Biochem J; 1984 Nov; 224(1):13-20. PubMed ID: 6508753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of in vivo oxidized high-density lipoproteins on platelet aggregation: evidence from patients with abetalipoproteinemia.
    Calzada C; Véricel E; Colas R; Guillot N; El Khoury G; Drai J; Sassolas A; Peretti N; Ponsin G; Lagarde M; Moulin P
    FASEB J; 2013 Jul; 27(7):2855-61. PubMed ID: 23507868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain.
    Puri RN; Zhou FX; Bradford H; Hu CJ; Colman RF; Colman RW
    Arch Biochem Biophys; 1989 Jun; 271(2):346-58. PubMed ID: 2543293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-stimulating effects of oxidized LDL are not attributable to toxic properties of the lipoproteins.
    Schmid W; Assinger A; Lee A; Bielek E; Koller E; Volf I
    Thromb Res; 2008; 122(5):630-9. PubMed ID: 18387657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of oxidatively modified low-density lipoproteins on platelet aggregability and membrane fluidity.
    Vlasova II
    Platelets; 2000 Nov; 11(7):406-14. PubMed ID: 11132108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet activation by oxidatively modified low density lipoproteins.
    Ardlie NG; Selley ML; Simons LA
    Atherosclerosis; 1989 Apr; 76(2-3):117-24. PubMed ID: 2730708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
    Puri RN; Colman RF; Colman RW
    Eur J Biochem; 1996 Mar; 236(3):862-70. PubMed ID: 8665907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Native and oxidized low density lipoproteins enhance platelet aggregation in whole blood.
    Tornvall P; Chirkova L; Toverud KD; Horowitz JD; Chirkov Y
    Thromb Res; 1999 Aug; 95(4):177-83. PubMed ID: 10498387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal by high-density lipoprotein of the effect of oxidized low-density lipoprotein on nitric oxide synthase protein expression in human platelets.
    Mehta JL; Chen LY
    J Lab Clin Med; 1996 Mar; 127(3):287-95. PubMed ID: 9273362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.